SMSPHARMA.BOSMSPHARMA.BOBSE
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank86
3Y CAGR+28.4%
5Y CAGR+30.1%
Studio
Year-over-Year Change

Price-to-earnings ratio

3Y CAGR
+28.4%/yr
vs -11.2%/yr prior
5Y CAGR
+30.1%/yr
Consistent
Acceleration
+39.6pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
3.7x
Strong expansion
Streak
1 yr
Consecutive declineElevated
PeriodValueYoY Change
202526.91-14.8%
202431.59+145.2%
2023-69.85-649.1%
202212.72-24.4%
202116.82+133.2%
20207.21-48.2%
201913.92-32.1%
201820.49+23.0%
201716.65+2.6%
201616.24-